ERBB2 and breast cancer: In addition, Kaplan-Meier survival analysis in 127 HER2+ BC patients showed that HER2+ patients with high GRB7 had shorter DFS compared to those with low GRB7 (Fig. S3G, HR = 3.275, 95%CI = 1.724–6.22, P < 0.001).